Regional Anesthesia EMG Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 9, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

December 31, 2025

Conditions
Surgery
Interventions
DEVICE

BlockSynop surface electromyography device

The EMG monitor uses non-invasive surface electrodes that measures electrical activity in response to muscle stimulation. After all electrodes have been placed on the patient, the electrodes will be connected to a prototype non-significant risk device (NSR) BlockSynop surface electromyography device and monitoring of sEMG signal will begin. The device is a non-invasive and non-significant risk device.

DRUG

Clonidine

Clonidine is an alpha-2-agonist which is commonly used as an adjunct in spinal anesthesia and caudal anesthesia to improve both the quality and duration of blockade.

DRUG

Sevoflurane

5.3. Sevoflurane is FDA approved for the induction and maintenance of general anesthesia in adults and pediatric patients.

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT06287151 - Regional Anesthesia EMG Study | Biotech Hunter | Biotech Hunter